COVID-19 Related Multi-System Inflammatory Syndrome in Children (MIS-C): A Systematic Review
Archives of Pediatric Infectious Diseases · 01.07.2024 · 12 (3)
DOI: 10.5812/apid-139928 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Pediatric Infectious Diseases, online erschienen am 01.07.2024. Verfasst von Sharareh Kamfar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Context
Multisystem inflammatory syndrome in children (MIS-C) is a severe condition associated with SARS-CoV-2. The underlying reasons why some children develop MIS-C remain unclear.
Objectives
To review and summarize the existing evidence about the epidemiological and clinical characteristics, laboratory findings, therapeutic management, and outcomes of patients with COVID-19-related MIS-C.
Methods
This systematic review followed PRISMA guidelines. We searched PubMed and Google Scholar for studies on COVID-19 and MIS-C. Out of the 2026 research articles generated from our initial search on PubMed and Google Scholar on 20 December 2022, 44 met the inclusion criteria and were included in the review. Data on demographics, clinical features, laboratory findings, treatment, and outcomes were extracted.
Results
The median age of 7297 MIS-C patients was 8.6 years, with 59.2% being male. The most common symptoms were fever (98.7%), rash (55.2%), and conjunctivitis (52.8%). Obesity (27.1%) was the most prevalent comorbidity. Fifty percent of patients were admitted to pediatric intensive care; 631 received inotropes, and 374 required mechanical ventilation. Over 80% received IV immunoglobulin, and 77% received corticosteroids. Abnormal echocardiograms occurred in 77.5% of cases, with coronary artery aneurysms present in 18.5%. Most patients recovered, with a reported mortality rate of 1.7%.
Conclusion
Despite the limitations, our systematic review provides valuable insights into the characteristics and management of MIS-C based on existing global literature. While a large number of patients required intensive care and various therapeutic interventions, favorable short-term outcomes were demonstrated in the majority of patients, with notably low mortality rates.
Zitieren
APA
Kamfar, S., Zeinali, V., Alaei, F., Farahbakhsh, N., Tabatabaee, S., & Mosallanejad, A. (2024). COVID-19 Related Multi-System Inflammatory Syndrome in Children (MIS-C): A Systematic Review. Archives of Pediatric Infectious Diseases, 12(3). https://doi.org/10.5812/apid-139928
Vancouver
Kamfar S, Zeinali V, Alaei F, Farahbakhsh N, Tabatabaee S, Mosallanejad A. COVID-19 Related Multi-System Inflammatory Syndrome in Children (MIS-C): A Systematic Review. Archives of Pediatric Infectious Diseases. 2024;12(3). doi:10.5812/apid-139928
BibTeX
@article{Kamfar2024,
author = {Kamfar, Sharareh and Zeinali, Vahide and Alaei, Fariba and Farahbakhsh, Nazanin and Tabatabaee, Shahrzad and Mosallanejad, Asieh},
title = {COVID-19 Related Multi-System Inflammatory Syndrome in Children (MIS-C): A Systematic Review},
journal = {Archives of Pediatric Infectious Diseases},
year = {2024},
volume = {12},
number = {3},
doi = {10.5812/apid-139928}
}
EUVIMED